Primary Site >> Colorectal Cancer
Gene >> IGF2BP3
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. PMID: 14613989 |
Ref: Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. PMID: 19140877 Ref: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. PMID: 19672661 |
Ref: Significant clinical response of advanced colon cancer to peptide vaccine therapy: a case report. PMID: 22763829 Ref: Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. PMID: 22840368 |
Ref: Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma. PMID: 24137402 Ref: Novel genes associated with colorectal cancer are revealed by high resolution cytogenetic analysis in a patient specific manner. PMID: 24204606 |
Ref: A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. PMID: 24612787 |
Ref: Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target. PMID: 26244168 |
Ref: Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications. PMID: 26984550 Ref: Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors. PMID: 27072896 |
Ref: Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. PMID: 28652767 Ref: Analysis of IMP3 expression in primary tumor and stromal cells in patients with colorectal cancer. PMID: 29344167 |
Ref: Epithelialmesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. PMID: 29115492 Ref: CircRNA circHIPK3 serves as a prognostic marker to promote glioma progression by regulating miR-654/IGF2BP3 signaling. PMID: 30057315 |